Clinical Trial Update: Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 trial of SHP639 eye drops in adults with primary open-angle glaucoma or ocular hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• SHP639 (SHP639)

Snippet

Sponsor: Shire | Conditions: Primary Open-angle Glaucoma (POAG), Ocular Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2019-08-07